{
  "directed": false,
  "multigraph": true,
  "graph": {},
  "nodes": [
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "treatment control",
      "Clinical_Age_At_Sampling": "64",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgG-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "15",
      "Clinical_Cytology": "8",
      "Clinical_sFLC_(mg/L)": "27",
      "Clinical_IGH_rearrangement": "0",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del13": "0",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_del16q_CYLDdel": "1",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "0",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group2",
      "Clinical_%_Myeloma_cells_by_PCY": "6.8",
      "Clinical_%_SmallPlasma_cells_by_PCY": "12.01",
      "Clinical_%_Plasma_cells_by_PCY": "18.81",
      "Clinical_%_M0_cells_by_PCY": "33.9",
      "Clinical_%_Other_cells_by_PCY": "29.39",
      "Clinical_%_T3_cells_by_PCY": "17.9",
      "role": "test",
      "Disease": "Multiple Myeloma",
      "Ixazomib_Proteasome Inhibitor regime__Predicted_Class": "no_effect",
      "Ixazomib_Proteasome Inhibitor regime__Predicted_Prob": 0.8810805082321167,
      "Lenalidomide_Corticosteroid + IMID__Predicted_Class": "no_effect",
      "Lenalidomide_Corticosteroid + IMID__Predicted_Prob": 0.9834588766098022,
      "Vincristine_Tubulin inhibitor__Predicted_Class": "positive_effect",
      "Vincristine_Tubulin inhibitor__Predicted_Prob": 0.6291677951812744,
      "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime__Predicted_Class": "no_effect",
      "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime__Predicted_Prob": 0.8282545208930969,
      "id": "MM062"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "untreated",
      "Clinical_Age_At_Sampling": "64",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgG-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "65",
      "Clinical_Cytology": "49",
      "Clinical_sFLC_(mg/L)": "168.7",
      "Clinical_IGH_rearrangement": "0",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del13": "0",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_del16q_CYLDdel": "1",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "0",
      "Clinical_Prior_IMID": "0",
      "Clinical_Prior_HD_Melphalan": "0",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group2",
      "Clinical_%_Myeloma_cells_by_PCY": "39.7",
      "Clinical_%_SmallPlasma_cells_by_PCY": "7.31",
      "Clinical_%_Plasma_cells_by_PCY": "47.01",
      "Clinical_%_M0_cells_by_PCY": "16.78",
      "Clinical_%_Other_cells_by_PCY": "11.55",
      "Clinical_%_T3_cells_by_PCY": "24.66",
      "role": "train",
      "id": "MM047"
    },
    {
      "Clinical_Diagnosis": "Plasma cell leukemia",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "control after allo-TPL",
      "Clinical_Age_At_Sampling": "63",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "f",
      "Clinical_Ig_Subtype": "na",
      "Clinical_Clonality": "not clonal",
      "Clinical_Pathology": "10",
      "Clinical_Cytology": "9.4",
      "Clinical_sFLC_(mg/L)": "178.4",
      "Clinical_IGH_rearrangement": "1",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "1",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_gain1q": "1",
      "Clinical_del13": "1",
      "Clinical_del17_TP53del": "1",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_del16q_CYLDdel": "1",
      "Clinical_Hyperdiploidy": "0",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "1",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group2",
      "Clinical_%_Myeloma_cells_by_PCY": "5.96",
      "Clinical_%_SmallPlasma_cells_by_PCY": "11.86",
      "Clinical_%_Plasma_cells_by_PCY": "17.82",
      "Clinical_%_M0_cells_by_PCY": "6.91",
      "Clinical_%_Other_cells_by_PCY": "43.42",
      "Clinical_%_T3_cells_by_PCY": "31.85",
      "role": "train",
      "id": "MM072"
    },
    {
      "Clinical_Diagnosis": "Smoldering myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "0",
      "Clinical_Treatment_stage": "untreated",
      "Clinical_Age_At_Sampling": "71",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "f",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgG-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "10",
      "Clinical_Cytology": "9",
      "Clinical_IGH_rearrangement": "1",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_gain1q": "1",
      "Clinical_del13": "0",
      "Clinical_del17_TP53del": "0",
      "Clinical_Prior_PI": "0",
      "Clinical_Prior_IMID": "0",
      "Clinical_Prior_HD_Melphalan": "0",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "0",
      "Clinical_PhenoGroups": "Group2",
      "Clinical_%_Myeloma_cells_by_PCY": "6.46",
      "Clinical_%_SmallPlasma_cells_by_PCY": "3.74",
      "Clinical_%_Plasma_cells_by_PCY": "10.2",
      "Clinical_%_M0_cells_by_PCY": "20.19",
      "Clinical_%_Other_cells_by_PCY": "18.98",
      "Clinical_%_T3_cells_by_PCY": "50.63",
      "role": "train",
      "id": "MM021"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "0",
      "Clinical_Treatment_stage": "untreated",
      "Clinical_Age_At_Sampling": "79",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Lambda",
      "Clinical_Ig_Subtype": "LC-Lambda",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "60",
      "Clinical_Cytology": "26",
      "Clinical_sFLC_(mg/L)": "3633.3",
      "Clinical_IGH_rearrangement": "1",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "1",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del13": "0",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "1",
      "Clinical_del16q_CYLDdel": "0",
      "Clinical_Hyperdiploidy": "0",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "0",
      "Clinical_Prior_IMID": "0",
      "Clinical_Prior_HD_Melphalan": "0",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "0",
      "Clinical_PhenoGroups": "Group3",
      "Clinical_%_Myeloma_cells_by_PCY": "9.87",
      "Clinical_%_SmallPlasma_cells_by_PCY": "10.44",
      "Clinical_%_Plasma_cells_by_PCY": "20.31",
      "Clinical_%_M0_cells_by_PCY": "1.19",
      "Clinical_%_Other_cells_by_PCY": "45.14",
      "Clinical_%_T3_cells_by_PCY": "33.36",
      "role": "train",
      "id": "MM046"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "3+",
      "Clinical_Treatment_stage": "relapse/progress",
      "Clinical_Age_At_Sampling": "79",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgG-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "25",
      "Clinical_Cytology": "18",
      "Clinical_sFLC_(mg/L)": "30",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "3",
      "Clinical_PhenoGroups": "Group3",
      "Clinical_%_Myeloma_cells_by_PCY": "6.24",
      "Clinical_%_SmallPlasma_cells_by_PCY": "20.65",
      "Clinical_%_Plasma_cells_by_PCY": "26.89",
      "Clinical_%_M0_cells_by_PCY": "7.02",
      "Clinical_%_Other_cells_by_PCY": "56.71",
      "Clinical_%_T3_cells_by_PCY": "9.37",
      "role": "train",
      "id": "MM042"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "relapse/progress",
      "Clinical_Age_At_Sampling": "69",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "f",
      "Clinical_Kap_Lam_clonality": "Lambda",
      "Clinical_Ig_Subtype": "IgG-Lambda",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "35",
      "Clinical_Cytology": "58",
      "Clinical_sFLC_(mg/L)": "1266",
      "Clinical_IGH_rearrangement": "1",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del13": "1",
      "Clinical_del17_TP53del": "1",
      "Clinical_del1p_SNX7del": "1",
      "Clinical_del16q_CYLDdel": "1",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group1",
      "Clinical_%_Myeloma_cells_by_PCY": "50.51",
      "Clinical_%_SmallPlasma_cells_by_PCY": "11.6",
      "Clinical_%_Plasma_cells_by_PCY": "62.11",
      "Clinical_%_M0_cells_by_PCY": "8.17",
      "Clinical_%_Other_cells_by_PCY": "13.39",
      "Clinical_%_T3_cells_by_PCY": "16.32",
      "role": "train",
      "id": "MM039"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "treatment control",
      "Clinical_Age_At_Sampling": "48",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgG-Kappa",
      "Clinical_Clonality": "not clonal",
      "Clinical_Cytology": "1.8",
      "Clinical_sFLC_(mg/L)": "15",
      "Clinical_IGH_rearrangement": "0",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del13": "0",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_del16q_CYLDdel": "1",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group3",
      "Clinical_%_Myeloma_cells_by_PCY": "11.33",
      "Clinical_%_SmallPlasma_cells_by_PCY": "6.01",
      "Clinical_%_Plasma_cells_by_PCY": "17.34",
      "Clinical_%_M0_cells_by_PCY": "14.96",
      "Clinical_%_Other_cells_by_PCY": "54.5",
      "Clinical_%_T3_cells_by_PCY": "13.21",
      "role": "train",
      "id": "MM069"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "treatment control",
      "Clinical_Age_At_Sampling": "69",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "f",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgG-Kappa",
      "Clinical_Clonality": "not clonal",
      "Clinical_sFLC_(mg/L)": "3.4",
      "Clinical_IGH_rearrangement": "0",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del13": "1",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "1",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group3",
      "Clinical_%_Myeloma_cells_by_PCY": "9.7",
      "Clinical_%_SmallPlasma_cells_by_PCY": "15.98",
      "Clinical_%_Plasma_cells_by_PCY": "25.67",
      "Clinical_%_M0_cells_by_PCY": "7.47",
      "Clinical_%_Other_cells_by_PCY": "59.47",
      "Clinical_%_T3_cells_by_PCY": "7.39",
      "role": "train",
      "id": "MM089"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "treatment control",
      "Clinical_Age_At_Sampling": "44",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "f",
      "Clinical_Kap_Lam_clonality": "Lambda",
      "Clinical_Ig_Subtype": "IgG-Lambda",
      "Clinical_Clonality": "not clonal",
      "Clinical_Cytology": "1.4",
      "Clinical_sFLC_(mg/L)": "1",
      "Clinical_IGH_rearrangement": "0",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del13": "1",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group2",
      "Clinical_%_Myeloma_cells_by_PCY": "3.95",
      "Clinical_%_SmallPlasma_cells_by_PCY": "10.91",
      "Clinical_%_Plasma_cells_by_PCY": "14.85",
      "Clinical_%_M0_cells_by_PCY": "10.77",
      "Clinical_%_Other_cells_by_PCY": "45.9",
      "Clinical_%_T3_cells_by_PCY": "28.48",
      "role": "train",
      "id": "MM078"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "relapse/progress",
      "Clinical_Age_At_Sampling": "55",
      "Clinical_Deceased": "1",
      "Clinical_Gender": "f",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgA-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "20",
      "Clinical_Cytology": "41",
      "Clinical_sFLC_(mg/L)": "14",
      "Clinical_IGH_rearrangement": "0",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del13": "0",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_del16q_CYLDdel": "0",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group1",
      "Clinical_%_Myeloma_cells_by_PCY": "37",
      "Clinical_%_SmallPlasma_cells_by_PCY": "5.83",
      "Clinical_%_Plasma_cells_by_PCY": "42.83",
      "Clinical_%_M0_cells_by_PCY": "8.09",
      "Clinical_%_Other_cells_by_PCY": "32.1",
      "Clinical_%_T3_cells_by_PCY": "16.97",
      "role": "train",
      "id": "MM058"
    },
    {
      "Clinical_Diagnosis": "Plasma cell leukemia",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "control after allo-TPL",
      "Clinical_Age_At_Sampling": "63",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "f",
      "Clinical_Ig_Subtype": "na",
      "Clinical_Clonality": "clonal",
      "Clinical_Cytology": "2.6",
      "Clinical_sFLC_(mg/L)": "83",
      "Clinical_IGH_rearrangement": "1",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "1",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_gain1q": "1",
      "Clinical_del13": "1",
      "Clinical_del17_TP53del": "1",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_del16q_CYLDdel": "1",
      "Clinical_Hyperdiploidy": "0",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "1",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group1",
      "Clinical_%_Myeloma_cells_by_PCY": "12.73",
      "Clinical_%_SmallPlasma_cells_by_PCY": "17.6",
      "Clinical_%_Plasma_cells_by_PCY": "30.34",
      "Clinical_%_M0_cells_by_PCY": "10.58",
      "Clinical_%_Other_cells_by_PCY": "50.44",
      "Clinical_%_T3_cells_by_PCY": "8.65",
      "role": "train",
      "id": "MM065"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "treatment control",
      "Clinical_Age_At_Sampling": "68",
      "Clinical_Deceased": "1",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "LC-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "15",
      "Clinical_Cytology": "12",
      "Clinical_sFLC_(mg/L)": "2246",
      "Clinical_IGH_rearrangement": "0",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del13": "0",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "0",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group1",
      "Clinical_%_Myeloma_cells_by_PCY": "18.06",
      "Clinical_%_SmallPlasma_cells_by_PCY": "16.06",
      "Clinical_%_Plasma_cells_by_PCY": "34.12",
      "Clinical_%_M0_cells_by_PCY": "6.71",
      "Clinical_%_Other_cells_by_PCY": "39.17",
      "Clinical_%_T3_cells_by_PCY": "20.01",
      "role": "train",
      "id": "MM094"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "3+",
      "Clinical_Treatment_stage": "treatment control",
      "Clinical_Age_At_Sampling": "51",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgG-Kappa",
      "Clinical_Clonality": "not clonal",
      "Clinical_Cytology": "1",
      "Clinical_sFLC_(mg/L)": "7",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "1",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "3",
      "Clinical_PhenoGroups": "Group3",
      "Clinical_%_Myeloma_cells_by_PCY": "5.23",
      "Clinical_%_SmallPlasma_cells_by_PCY": "28.17",
      "Clinical_%_Plasma_cells_by_PCY": "33.4",
      "Clinical_%_M0_cells_by_PCY": "8.71",
      "Clinical_%_Other_cells_by_PCY": "45.43",
      "Clinical_%_T3_cells_by_PCY": "12.45",
      "role": "train",
      "id": "MM036"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "treatment control",
      "Clinical_Age_At_Sampling": "69",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "LC-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "50",
      "Clinical_Cytology": "13",
      "Clinical_sFLC_(mg/L)": "712.5",
      "Clinical_IGH_rearrangement": "0",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_del13": "0",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_del16q_CYLDdel": "0",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "0",
      "Clinical_Prior_HD_Melphalan": "0",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group1",
      "Clinical_%_Myeloma_cells_by_PCY": "26.33",
      "Clinical_%_SmallPlasma_cells_by_PCY": "21.99",
      "Clinical_%_Plasma_cells_by_PCY": "48.32",
      "Clinical_%_M0_cells_by_PCY": "12.03",
      "Clinical_%_Other_cells_by_PCY": "30.6",
      "Clinical_%_T3_cells_by_PCY": "9.05",
      "role": "train",
      "id": "MM023"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "treatment control",
      "Clinical_Age_At_Sampling": "66",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "f",
      "Clinical_Kap_Lam_clonality": "Lambda",
      "Clinical_Ig_Subtype": "IgG-Lambda",
      "Clinical_Clonality": "not clonal",
      "Clinical_Cytology": "2",
      "Clinical_sFLC_(mg/L)": "4",
      "Clinical_del13": "0",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "1",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group1",
      "Clinical_%_Myeloma_cells_by_PCY": "23.26",
      "Clinical_%_SmallPlasma_cells_by_PCY": "2.62",
      "Clinical_%_Plasma_cells_by_PCY": "25.87",
      "Clinical_%_M0_cells_by_PCY": "6.13",
      "Clinical_%_Other_cells_by_PCY": "54.99",
      "Clinical_%_T3_cells_by_PCY": "13",
      "role": "train",
      "id": "MM079"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "3+",
      "Clinical_Treatment_stage": "relapse/progress",
      "Clinical_Age_At_Sampling": "79",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgA-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Cytology": "1",
      "Clinical_sFLC_(mg/L)": "501",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "0",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "3",
      "Clinical_PhenoGroups": "Group3",
      "Clinical_%_Myeloma_cells_by_PCY": "11.35",
      "Clinical_%_SmallPlasma_cells_by_PCY": "8.43",
      "Clinical_%_Plasma_cells_by_PCY": "19.77",
      "Clinical_%_M0_cells_by_PCY": "6.34",
      "Clinical_%_Other_cells_by_PCY": "62.75",
      "Clinical_%_T3_cells_by_PCY": "11.13",
      "role": "train",
      "id": "MM033"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "0",
      "Clinical_Treatment_stage": "untreated",
      "Clinical_Age_At_Sampling": "40",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgG-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "12",
      "Clinical_Cytology": "17",
      "Clinical_sFLC_(mg/L)": "68.4",
      "Clinical_IGH_rearrangement": "0",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del17_TP53del": "1",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_del16q_CYLDdel": "0",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "0",
      "Clinical_Prior_IMID": "0",
      "Clinical_Prior_HD_Melphalan": "0",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "0",
      "Clinical_PhenoGroups": "Group2",
      "Clinical_%_Myeloma_cells_by_PCY": "4.86",
      "Clinical_%_SmallPlasma_cells_by_PCY": "7.81",
      "Clinical_%_Plasma_cells_by_PCY": "12.68",
      "Clinical_%_M0_cells_by_PCY": "23.73",
      "Clinical_%_Other_cells_by_PCY": "12.56",
      "Clinical_%_T3_cells_by_PCY": "51.03",
      "role": "train",
      "id": "MM037"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "treatment control",
      "Clinical_Age_At_Sampling": "69",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "LC-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Cytology": "2",
      "Clinical_sFLC_(mg/L)": "118",
      "Clinical_IGH_rearrangement": "0",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_del13": "0",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_del16q_CYLDdel": "0",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "0",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group3",
      "Clinical_%_Myeloma_cells_by_PCY": "14.98",
      "Clinical_%_SmallPlasma_cells_by_PCY": "18.14",
      "Clinical_%_Plasma_cells_by_PCY": "33.11",
      "Clinical_%_M0_cells_by_PCY": "7.75",
      "Clinical_%_Other_cells_by_PCY": "55.11",
      "Clinical_%_T3_cells_by_PCY": "4.02",
      "role": "train",
      "id": "MM053"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "3+",
      "Clinical_Treatment_stage": "relapse/progress",
      "Clinical_Age_At_Sampling": "62",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Lambda",
      "Clinical_Ig_Subtype": "IgG-Lambda",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "7",
      "Clinical_Cytology": "2",
      "Clinical_sFLC_(mg/L)": "711",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "1",
      "Clinical_Prior_Number_of_Treatment_Lines": "3",
      "Clinical_PhenoGroups": "Group2",
      "Clinical_%_Myeloma_cells_by_PCY": "3.18",
      "Clinical_%_SmallPlasma_cells_by_PCY": "4.99",
      "Clinical_%_Plasma_cells_by_PCY": "8.17",
      "Clinical_%_M0_cells_by_PCY": "10.78",
      "Clinical_%_Other_cells_by_PCY": "24.26",
      "Clinical_%_T3_cells_by_PCY": "56.79",
      "role": "train",
      "id": "MM028"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "0",
      "Clinical_Treatment_stage": "untreated",
      "Clinical_Age_At_Sampling": "74",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "f",
      "Clinical_Kap_Lam_clonality": "Lambda",
      "Clinical_Ig_Subtype": "LC-Lambda",
      "Clinical_Clonality": "clonal",
      "Clinical_Cytology": "19",
      "Clinical_sFLC_(mg/L)": "1258.2",
      "Clinical_IGH_rearrangement": "1",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "1",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del13": "0",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_Hyperdiploidy": "0",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "0",
      "Clinical_Prior_IMID": "0",
      "Clinical_Prior_HD_Melphalan": "0",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "0",
      "Clinical_PhenoGroups": "Group1",
      "Clinical_%_Myeloma_cells_by_PCY": "21.17",
      "Clinical_%_SmallPlasma_cells_by_PCY": "27.51",
      "Clinical_%_Plasma_cells_by_PCY": "48.68",
      "Clinical_%_M0_cells_by_PCY": "5.93",
      "Clinical_%_Other_cells_by_PCY": "33.32",
      "Clinical_%_T3_cells_by_PCY": "12.08",
      "role": "train",
      "id": "MM061"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "0",
      "Clinical_Treatment_stage": "untreated",
      "Clinical_Age_At_Sampling": "55",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Lambda",
      "Clinical_Ig_Subtype": "IgG-Lambda",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "10",
      "Clinical_Cytology": "24",
      "Clinical_sFLC_(mg/L)": "109.8",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_del17_TP53del": "0",
      "Clinical_Prior_PI": "0",
      "Clinical_Prior_IMID": "0",
      "Clinical_Prior_HD_Melphalan": "0",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "0",
      "Clinical_PhenoGroups": "Group2",
      "Clinical_%_Myeloma_cells_by_PCY": "16.79",
      "Clinical_%_SmallPlasma_cells_by_PCY": "16.82",
      "Clinical_%_Plasma_cells_by_PCY": "33.62",
      "Clinical_%_M0_cells_by_PCY": "11.6",
      "Clinical_%_Other_cells_by_PCY": "24.33",
      "Clinical_%_T3_cells_by_PCY": "30.45",
      "role": "train",
      "id": "MM082"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "treatment control",
      "Clinical_Age_At_Sampling": "64",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgG-Kappa",
      "Clinical_Clonality": "not clonal",
      "Clinical_Cytology": "0.6",
      "Clinical_sFLC_(mg/L)": "14",
      "Clinical_IGH_rearrangement": "0",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del13": "0",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_del16q_CYLDdel": "1",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group3",
      "Clinical_%_Myeloma_cells_by_PCY": "4.16",
      "Clinical_%_SmallPlasma_cells_by_PCY": "22.54",
      "Clinical_%_Plasma_cells_by_PCY": "26.69",
      "Clinical_%_M0_cells_by_PCY": "12.79",
      "Clinical_%_Other_cells_by_PCY": "53.47",
      "Clinical_%_T3_cells_by_PCY": "7.05",
      "role": "train",
      "id": "MM075"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "0",
      "Clinical_Treatment_stage": "untreated",
      "Clinical_Age_At_Sampling": "80",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgG-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "80",
      "Clinical_Cytology": "49",
      "Clinical_sFLC_(mg/L)": "853.7",
      "Clinical_IGH_rearrangement": "1",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "1",
      "Clinical_gain1q": "1",
      "Clinical_del13": "0",
      "Clinical_del17_TP53del": "0",
      "Clinical_Prior_PI": "0",
      "Clinical_Prior_IMID": "0",
      "Clinical_Prior_HD_Melphalan": "0",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "0",
      "Clinical_PhenoGroups": "Group2",
      "Clinical_%_Myeloma_cells_by_PCY": "8.95",
      "Clinical_%_SmallPlasma_cells_by_PCY": "12.14",
      "Clinical_%_Plasma_cells_by_PCY": "21.09",
      "Clinical_%_M0_cells_by_PCY": "18.57",
      "Clinical_%_Other_cells_by_PCY": "19.81",
      "Clinical_%_T3_cells_by_PCY": "40.53",
      "role": "train",
      "id": "MM051"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "2",
      "Clinical_Treatment_stage": "treatment control",
      "Clinical_Age_At_Sampling": "64",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "f",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgA-Kappa",
      "Clinical_Clonality": "not clonal",
      "Clinical_Pathology": "7",
      "Clinical_Cytology": "7.6",
      "Clinical_sFLC_(mg/L)": "11",
      "Clinical_IGH_rearrangement": "1",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del13": "1",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "2",
      "Clinical_PhenoGroups": "Group2",
      "Clinical_%_Myeloma_cells_by_PCY": "4.29",
      "Clinical_%_SmallPlasma_cells_by_PCY": "13.99",
      "Clinical_%_Plasma_cells_by_PCY": "18.28",
      "Clinical_%_M0_cells_by_PCY": "13.58",
      "Clinical_%_Other_cells_by_PCY": "19.49",
      "Clinical_%_T3_cells_by_PCY": "48.65",
      "role": "train",
      "id": "MM059"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "0",
      "Clinical_Treatment_stage": "untreated",
      "Clinical_Age_At_Sampling": "69",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Lambda",
      "Clinical_Ig_Subtype": "LC-Lambda",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "90",
      "Clinical_Cytology": "70",
      "Clinical_del13": "1",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "1",
      "Clinical_del16q_CYLDdel": "1",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "0",
      "Clinical_Prior_IMID": "0",
      "Clinical_Prior_HD_Melphalan": "0",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "0",
      "Clinical_PhenoGroups": "Group1",
      "Clinical_%_Myeloma_cells_by_PCY": "53.49",
      "Clinical_%_SmallPlasma_cells_by_PCY": "9.14",
      "Clinical_%_Plasma_cells_by_PCY": "62.63",
      "Clinical_%_M0_cells_by_PCY": "3.06",
      "Clinical_%_Other_cells_by_PCY": "15.5",
      "Clinical_%_T3_cells_by_PCY": "18.82",
      "role": "train",
      "id": "MM027"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "treatment control",
      "Clinical_Age_At_Sampling": "65",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgG-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "6",
      "Clinical_Cytology": "3",
      "Clinical_sFLC_(mg/L)": "53",
      "Clinical_IGH_rearrangement": "0",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del17_TP53del": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "0",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group3",
      "Clinical_%_Myeloma_cells_by_PCY": "9.58",
      "Clinical_%_SmallPlasma_cells_by_PCY": "7.52",
      "Clinical_%_Plasma_cells_by_PCY": "17.11",
      "Clinical_%_M0_cells_by_PCY": "14.17",
      "Clinical_%_Other_cells_by_PCY": "51.06",
      "Clinical_%_T3_cells_by_PCY": "17.66",
      "role": "train",
      "id": "MM025"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "0",
      "Clinical_Treatment_stage": "untreated",
      "Clinical_Age_At_Sampling": "59",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Lambda",
      "Clinical_Ig_Subtype": "IgG-Lambda",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "60",
      "Clinical_Cytology": "44",
      "Clinical_sFLC_(mg/L)": "533",
      "Clinical_IGH_rearrangement": "0",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del13": "1",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_del16q_CYLDdel": "0",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "0",
      "Clinical_Prior_IMID": "0",
      "Clinical_Prior_HD_Melphalan": "0",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "0",
      "Clinical_PhenoGroups": "Group1",
      "Clinical_%_Myeloma_cells_by_PCY": "39.59",
      "Clinical_%_SmallPlasma_cells_by_PCY": "10.65",
      "Clinical_%_Plasma_cells_by_PCY": "50.23",
      "Clinical_%_M0_cells_by_PCY": "12.1",
      "Clinical_%_Other_cells_by_PCY": "25.81",
      "Clinical_%_T3_cells_by_PCY": "11.85",
      "role": "train",
      "id": "MM026"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "3+",
      "Clinical_Treatment_stage": "control after allo-TPL",
      "Clinical_Age_At_Sampling": "60",
      "Clinical_Deceased": "1",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgG-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Cytology": "5",
      "Clinical_sFLC_(mg/L)": "28",
      "Clinical_IGH_rearrangement": "1",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "1",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_del13": "0",
      "Clinical_del17_TP53del": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "1",
      "Clinical_Prior_Number_of_Treatment_Lines": "4",
      "Clinical_PhenoGroups": "Group3",
      "Clinical_%_Myeloma_cells_by_PCY": "5.23",
      "Clinical_%_SmallPlasma_cells_by_PCY": "3.14",
      "Clinical_%_Plasma_cells_by_PCY": "8.36",
      "Clinical_%_M0_cells_by_PCY": "10.62",
      "Clinical_%_Other_cells_by_PCY": "46.27",
      "Clinical_%_T3_cells_by_PCY": "34.74",
      "role": "train",
      "id": "MM048"
    },
    {
      "Clinical_Diagnosis": "Plasma cell leukemia",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "control after allo-TPL",
      "Clinical_Age_At_Sampling": "63",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "f",
      "Clinical_Ig_Subtype": "na",
      "Clinical_Clonality": "not clonal",
      "Clinical_Pathology": "25",
      "Clinical_Cytology": "22.6",
      "Clinical_sFLC_(mg/L)": "332",
      "Clinical_IGH_rearrangement": "1",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "1",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_gain1q": "1",
      "Clinical_del13": "1",
      "Clinical_del17_TP53del": "1",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_del16q_CYLDdel": "1",
      "Clinical_Hyperdiploidy": "0",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "1",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group2",
      "Clinical_%_Myeloma_cells_by_PCY": "3.71",
      "Clinical_%_SmallPlasma_cells_by_PCY": "4.58",
      "Clinical_%_Plasma_cells_by_PCY": "8.29",
      "Clinical_%_M0_cells_by_PCY": "10.71",
      "Clinical_%_Other_cells_by_PCY": "28.42",
      "Clinical_%_T3_cells_by_PCY": "52.58",
      "role": "train",
      "id": "MM077"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "0",
      "Clinical_Treatment_stage": "untreated",
      "Clinical_Age_At_Sampling": "69",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "f",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgA-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Cytology": "25.8",
      "Clinical_sFLC_(mg/L)": "6006",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_del17_TP53del": "0",
      "Clinical_Prior_PI": "0",
      "Clinical_Prior_IMID": "0",
      "Clinical_Prior_HD_Melphalan": "0",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "0",
      "Clinical_PhenoGroups": "Group1",
      "Clinical_%_Myeloma_cells_by_PCY": "16.74",
      "Clinical_%_SmallPlasma_cells_by_PCY": "33.89",
      "Clinical_%_Plasma_cells_by_PCY": "50.63",
      "Clinical_%_M0_cells_by_PCY": "6.7",
      "Clinical_%_Other_cells_by_PCY": "29.85",
      "Clinical_%_T3_cells_by_PCY": "12.83",
      "role": "train",
      "id": "MM067"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "relapse/progress",
      "Clinical_Age_At_Sampling": "68",
      "Clinical_Deceased": "1",
      "Clinical_Gender": "f",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgG-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "7",
      "Clinical_Cytology": "7",
      "Clinical_sFLC_(mg/L)": "194",
      "Clinical_IGH_rearrangement": "0",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del13": "0",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_del16q_CYLDdel": "0",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group3",
      "Clinical_%_Myeloma_cells_by_PCY": "23.22",
      "Clinical_%_SmallPlasma_cells_by_PCY": "7.12",
      "Clinical_%_Plasma_cells_by_PCY": "30.34",
      "Clinical_%_M0_cells_by_PCY": "9.15",
      "Clinical_%_Other_cells_by_PCY": "37.1",
      "Clinical_%_T3_cells_by_PCY": "23.41",
      "role": "train",
      "id": "MM070"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "0",
      "Clinical_Treatment_stage": "untreated",
      "Clinical_Age_At_Sampling": "60",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgG-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "50",
      "Clinical_Cytology": "26",
      "Clinical_sFLC_(mg/L)": "305.9",
      "Clinical_MYC_amp": "0",
      "Clinical_del13": "1",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_del16q_CYLDdel": "0",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "0",
      "Clinical_Prior_IMID": "0",
      "Clinical_Prior_HD_Melphalan": "0",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "0",
      "Clinical_PhenoGroups": "Group3",
      "Clinical_%_Myeloma_cells_by_PCY": "29.92",
      "Clinical_%_SmallPlasma_cells_by_PCY": "11.24",
      "Clinical_%_Plasma_cells_by_PCY": "41.17",
      "Clinical_%_M0_cells_by_PCY": "2.28",
      "Clinical_%_Other_cells_by_PCY": "37.45",
      "Clinical_%_T3_cells_by_PCY": "19.11",
      "role": "train",
      "id": "MM103"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "2",
      "Clinical_Treatment_stage": "relapse/progress",
      "Clinical_Age_At_Sampling": "53",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgG-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "65",
      "Clinical_Cytology": "49",
      "Clinical_sFLC_(mg/L)": "7110.1",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "2",
      "Clinical_PhenoGroups": "Group3",
      "Clinical_%_Myeloma_cells_by_PCY": "12.85",
      "Clinical_%_SmallPlasma_cells_by_PCY": "23.4",
      "Clinical_%_Plasma_cells_by_PCY": "36.25",
      "Clinical_%_M0_cells_by_PCY": "1.77",
      "Clinical_%_Other_cells_by_PCY": "58.56",
      "Clinical_%_T3_cells_by_PCY": "3.42",
      "role": "train",
      "id": "MM106"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "treatment control",
      "Clinical_Age_At_Sampling": "63",
      "Clinical_Deceased": "1",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgG-Kappa",
      "Clinical_Clonality": "not clonal",
      "Clinical_Cytology": "2",
      "Clinical_sFLC_(mg/L)": "32.1",
      "Clinical_IGH_rearrangement": "0",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del17_TP53del": "1",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group3",
      "Clinical_%_Myeloma_cells_by_PCY": "5.55",
      "Clinical_%_SmallPlasma_cells_by_PCY": "19.96",
      "Clinical_%_Plasma_cells_by_PCY": "25.52",
      "Clinical_%_M0_cells_by_PCY": "14.41",
      "Clinical_%_Other_cells_by_PCY": "47.25",
      "Clinical_%_T3_cells_by_PCY": "12.83",
      "role": "train",
      "id": "MM044"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "2",
      "Clinical_Treatment_stage": "relapse/progress",
      "Clinical_Age_At_Sampling": "81",
      "Clinical_Deceased": "1",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgG-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Cytology": "6",
      "Clinical_IGH_rearrangement": "0",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_MYC_amp": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del13": "1",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_del16q_CYLDdel": "0",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "1",
      "Clinical_Prior_HD_Melphalan": "0",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "2",
      "Clinical_PhenoGroups": "Group2",
      "Clinical_%_Myeloma_cells_by_PCY": "10.86",
      "Clinical_%_SmallPlasma_cells_by_PCY": "8.02",
      "Clinical_%_Plasma_cells_by_PCY": "18.88",
      "Clinical_%_M0_cells_by_PCY": "12.56",
      "Clinical_%_Other_cells_by_PCY": "26.37",
      "Clinical_%_T3_cells_by_PCY": "42.19",
      "role": "train",
      "id": "MM092"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "1",
      "Clinical_Treatment_stage": "relapse/progress",
      "Clinical_Age_At_Sampling": "75",
      "Clinical_Deceased": "1",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgA-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Cytology": "50",
      "Clinical_sFLC_(mg/L)": "940",
      "Clinical_Prior_PI": "1",
      "Clinical_Prior_IMID": "0",
      "Clinical_Prior_HD_Melphalan": "1",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "1",
      "Clinical_PhenoGroups": "Group1",
      "Clinical_%_Myeloma_cells_by_PCY": "28.37",
      "Clinical_%_SmallPlasma_cells_by_PCY": "13.77",
      "Clinical_%_Plasma_cells_by_PCY": "42.14",
      "Clinical_%_M0_cells_by_PCY": "8.66",
      "Clinical_%_Other_cells_by_PCY": "39.4",
      "Clinical_%_T3_cells_by_PCY": "9.81",
      "role": "train",
      "id": "MM084"
    },
    {
      "Clinical_Diagnosis": "Plasma cell myeloma",
      "Clinical_Prior_Treatment_Lines_simplified": "0",
      "Clinical_Treatment_stage": "untreated",
      "Clinical_Age_At_Sampling": "43",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "f",
      "Clinical_Kap_Lam_clonality": "Lambda",
      "Clinical_Ig_Subtype": "IgG-Lambda",
      "Clinical_Clonality": "clonal",
      "Clinical_Pathology": "17",
      "Clinical_Cytology": "30",
      "Clinical_sFLC_(mg/L)": "170",
      "Clinical_IGH_rearrangement": "0",
      "Clinical_t(4;14)_IGH_FGFR3": "0",
      "Clinical_t(11;14)_IGH_CCND1": "0",
      "Clinical_t(14;16)_IGH_MAF": "0",
      "Clinical_t(14;20)_IGH_MAFB": "0",
      "Clinical_MYC_breakapart": "0",
      "Clinical_del13": "1",
      "Clinical_del17_TP53del": "0",
      "Clinical_del1p_SNX7del": "0",
      "Clinical_Hyperdiploidy": "1",
      "Clinical_Hypodiploidy": "0",
      "Clinical_Prior_PI": "0",
      "Clinical_Prior_IMID": "0",
      "Clinical_Prior_HD_Melphalan": "0",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "0",
      "Clinical_PhenoGroups": "Group2",
      "Clinical_%_Myeloma_cells_by_PCY": "19.9",
      "Clinical_%_SmallPlasma_cells_by_PCY": "9.33",
      "Clinical_%_Plasma_cells_by_PCY": "29.22",
      "Clinical_%_M0_cells_by_PCY": "11.29",
      "Clinical_%_Other_cells_by_PCY": "27.63",
      "Clinical_%_T3_cells_by_PCY": "31.85",
      "role": "train",
      "id": "MM049"
    },
    {
      "Clinical_Diagnosis": "MGUS",
      "Clinical_Prior_Treatment_Lines_simplified": "0",
      "Clinical_Treatment_stage": "untreated",
      "Clinical_Age_At_Sampling": "54",
      "Clinical_Deceased": "0",
      "Clinical_Gender": "m",
      "Clinical_Kap_Lam_clonality": "Kappa",
      "Clinical_Ig_Subtype": "IgG-Kappa/IgA-Kappa",
      "Clinical_Clonality": "clonal",
      "Clinical_Cytology": "9",
      "Clinical_Prior_PI": "0",
      "Clinical_Prior_IMID": "0",
      "Clinical_Prior_HD_Melphalan": "0",
      "Clinical_Prior_Immunotherapy": "0",
      "Clinical_Prior_AlloTPL": "0",
      "Clinical_Prior_Number_of_Treatment_Lines": "0",
      "Clinical_PhenoGroups": "Group2",
      "Clinical_%_Myeloma_cells_by_PCY": "19.09",
      "Clinical_%_SmallPlasma_cells_by_PCY": "15.44",
      "Clinical_%_Plasma_cells_by_PCY": "34.53",
      "Clinical_%_M0_cells_by_PCY": "23.36",
      "Clinical_%_Other_cells_by_PCY": "12.19",
      "Clinical_%_T3_cells_by_PCY": "29.92",
      "role": "train",
      "id": "MM081"
    }
  ],
  "links": [
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM047",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM047",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM047",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM072",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM072",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM072",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "adverse_effect",
      "source": "MM062",
      "target": "MM021",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM021",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM021",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM046",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM046",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM046",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "adverse_effect",
      "source": "MM062",
      "target": "MM046",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "adverse_effect",
      "source": "MM062",
      "target": "MM042",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM042",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM039",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM039",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM039",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM069",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM069",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM069",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM089",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM089",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM089",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM089",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM078",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM078",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM078",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM058",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM058",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM058",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM058",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM065",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM065",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM065",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM065",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM094",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM094",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM094",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM094",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "adverse_effect",
      "source": "MM062",
      "target": "MM036",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "adverse_effect",
      "source": "MM062",
      "target": "MM036",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM036",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM036",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM023",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM023",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM023",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM023",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM079",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM079",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM079",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM033",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "adverse_effect",
      "source": "MM062",
      "target": "MM033",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM033",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM033",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "adverse_effect",
      "source": "MM062",
      "target": "MM037",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM037",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM053",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM053",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM053",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM053",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM028",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM028",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "adverse_effect",
      "source": "MM062",
      "target": "MM028",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM028",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM061",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM061",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM061",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM061",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM082",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM082",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM082",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM075",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM075",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM075",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "adverse_effect",
      "source": "MM062",
      "target": "MM051",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM051",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "adverse_effect",
      "source": "MM062",
      "target": "MM059",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM059",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM059",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM027",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM027",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM027",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM027",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM025",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM025",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM025",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM025",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM026",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM026",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM026",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM026",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM048",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM048",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM048",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM048",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM077",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM077",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM077",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM067",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "adverse_effect",
      "source": "MM062",
      "target": "MM067",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Ixazomib_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8810805082321167,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM070",
      "key": "Ixazomib_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "adverse_effect",
      "source": "MM062",
      "target": "MM070",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM070",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM070",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM103",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM103",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM103",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM106",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM106",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM106",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM044",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM044",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "adverse_effect",
      "source": "MM062",
      "target": "MM044",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM092",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "positive_effect",
      "source": "MM062",
      "target": "MM092",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM092",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM084",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM084",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM049",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Vincristine_Tubulin inhibitor",
      "Predicted_Class": "positive_effect",
      "Predicted_Prob": 0.6291677951812744,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM049",
      "key": "Vincristine_Tubulin inhibitor"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM049",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    },
    {
      "drug": "Lenalidomide_Corticosteroid + IMID",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.9834588766098022,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM081",
      "key": "Lenalidomide_Corticosteroid + IMID"
    },
    {
      "drug": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime",
      "Predicted_Class": "no_effect",
      "Predicted_Prob": 0.8282545208930969,
      "Training_True_Class": "no_effect",
      "source": "MM062",
      "target": "MM081",
      "key": "Dexamethasone+Ixazomib+Lenalidomide_Proteasome Inhibitor regime"
    }
  ]
}